Christopher Posner is CEO & President at Cara Therapeutics, Inc. (CARA). They have made 3 open-market trades across 1 company since 2020, most recently 2025-02-28.
CIK 0001748265
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CARA | 13,109 | $70K |
Shares reported on the most recent Form 4, priced at the 2025-03-04 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CARA | SELL · 10b5-1 | 2025-02-28 | 2025-03-04 | $4.75 | $3K | +19.3% | +15.1% | N/A |
| CARA | SELL · 10b5-1 | 2025-02-04 | 2025-02-06 | $4.72 | $2K | +0.2% | -2.0% | N/A |
| CARA | SELL · 10b5-1 | 2024-11-04 | 2024-11-06 | $0.29 | $1K | -8.6% | -16.9% | +27.9% |
| CARA | SELL · 10b5-1 | 2024-08-01 | 2024-08-02 | $0.35 | $1K | +2.7% | +3.4% | -3.0% |
| CARA | SELL · 10b5-1 | 2024-05-02 | 2024-05-06 | $0.75 | $3K | -0.5% | -14.1% | -57.2% |
| CARA | SELL · 10b5-1 | 2024-02-29 | 2024-03-04 | $0.89 | $5K | -11.0% | +2.6% | -23.1% |
| CARA | SELL · 10b5-1 | 2024-02-08 | 2024-02-12 | $0.53 | $19K | +56.2% | +49.7% | +29.1% |
| CARA | SELL · 10b5-1 | 2024-02-01 | 2024-02-05 | $0.55 | $3K | +2.6% | +70.7% | +36.2% |
| CARA | SELL · 10b5-1 | 2023-11-02 | 2023-11-03 | $1.22 | $5K | -19.4% | -26.6% | -59.6% |
| CARA | SELL · 10b5-1 | 2023-08-03 | 2023-08-04 | $3.07 | $13K | -5.5% | -30.3% | -61.6% |
| CARA | SELL · 10b5-1 | 2023-05-05 | 2023-05-09 | $4.40 | $17K | -11.0% | -23.5% | -30.8% |
| CARA | SELL | 2023-03-03 | 2023-03-07 | $9.71 | $116K | -11.5% | -25.4% | -48.9% |
| CARA | SELL · 10b5-1 | 2023-02-02 | 2023-02-03 | $11.80 | $49K | -15.2% | -18.0% | -64.4% |
| CARA | SELL | 2022-11-16 | 2022-11-18 | $11.13 | $322K | +10.0% | +3.4% | -4.3% |
| CARA | SELL · 10b5-1 | 2022-04-04 | 2022-04-05 | $12.67 | $25K | +5.5% | -32.9% | -26.8% |
| CARA | SELL · 10b5-1 | 2021-06-07 | 2021-06-07 | $13.04 | $30K | +8.8% | +2.8% | +16.0% |
| CARA | SELL | 2020-11-19 | 2020-11-23 | $15.82 | $32K | +0.5% | +4.7% | +34.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.